The Patent Finder

Terms ending in 2037

Cardea Bio, Inc.

Every in-force patent on Cardea Bio, Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,811,539Graphene Fet Devices, Systems, and Methods of Using the Same for Sequencing Nucleic Acids
In force
 · High confidence
Cardea Bio, Inc.In forceHigh confidence
US 10,395,928Depositing a Passivation Layer on a Graphene Sheet
In force
 · High confidence
Cardea Bio, Inc.In forceHigh confidence
US 11,056,343Providing a Temporary Protective Layer on a Graphene Sheet
In force
 · Medium confidence
Nanomedical Diagnostics, Inc.In forceMedium confidence
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited